The Sceptic

Would Genentech Be Better Off Left Alone by Roche?

If this is just a ploy by Roche to toy with DNA to get the book value up, it will fall flat on its face when the final rejection comes.

I have an idea/suggestion - It will be a stretch for DNA to arrange for finances to buy the entire 56% of its equity that Roche owns. But it might be possible to buy out a much smaller % - say 7% - to bring Roche's ownership from a controlling one to minority ownership. Ofcourse it will take some negotiations to do that but if Roche is not willing to pony up another 20 bucks. This would be a win-win deal for both Roche and DNA ... it will bring new resurgence to the company's employees as well as the share prices.

10 Software Predictions for 2008

How can a list of predictions in the software industry be any good without the word "Apple"?

Biogen Idec: The Trouble With Stocks

Call me a sceptic but it would be interesting to know if any insiders sold shares during this "review of strategic options period" which might be a farce to jack up the stock price so they can sell their shares.

Coming to think of it, every company should put themselves on the market once every other year and give everyone time to cash out then take themselves off the market!